You searched for covid-19 | Page 70 of 372

FDA Grants InBios First Marketing Rights for Anthrax POC Test

Posted by Andy Lundin | Mar 3, 2023 | POC Rapid Assays |

InBios has been granted the U.S. Food and Drug Administration’s (FDA) first marketing rights for an anthrax point-of-care (POC) test.

Automated NGS platforms can help determine if a patient is fit for a targeted therapy, enabling more effective precision medicine.

Proscia Co-founder and Chief Product Officer Nathan Buchbinder outlines why digital pathology adoption will be aided by new CPT codes.

Posted by Andy Lundin | Mar 2, 2023 | Covid 19 |

Cue Health and Pfizer are collaborating to raise awareness for those with underlying conditions of the risks of progressing to severe COVID.

Posted by Andy Lundin | Mar 2, 2023 | Covid 19 |

A study by Rice University and the Houston Health Department shows wastewater monitoring is effective at detecting viral outbreaks in schools.